| 09.00 - 10.00 |
Wolfson Theatre |
|
|
Plenary Lecture: Asia and Oceanic Medal Lecture |
|
|
Chair: Franks S (London) |
| |
|
|
| S3 |
09.00 |
New
frontiers of estrogen action |
|
|
Simpson ER (Clayton, Australia) |
| |
|
|
| 10.00 - 10.30 |
Osler Room |
|
|
COFFEE |
| |
|
|
| 10.30 - 12.30 |
Wolfson Theatre |
|
|
Symposium 3: Transcriptional control of endocrine
development and function |
|
|
Chairperson: Burrin J (London) & Parker M (London) |
| |
|
|
| S13 |
10.30 |
Cell
fate and hormonal regulation of the pituitary gonadotrope |
|
|
Mellon PA (San Diego, USA), Jacobs S, Bailey J, Spady
T, Coss D, Vasilyev V & Pernasetti F |
| |
|
|
| S14 |
11.00 |
Inherited
disorders of adrenal development |
|
|
Achermann JC (London) |
| |
|
|
| S15 |
11.30 |
Genetic
control of sex differentiation |
|
|
Hughes IA (Cambridge), Martin H & Jaaskelainen J |
| |
|
|
| S16 |
12.00 |
Parathyroid
development |
|
|
Thakker RV (Oxford) |
| |
|
|
| 10.30 - 12.30 |
Council Chamber |
|
|
Oral Communication 3: Steroid hormone action |
|
|
Chair: Hinson J (London) & Hewison M (Birmingham) |
| |
|
|
| OC17* |
10.30 |
Evidence
from co-culture studies that annexin 1 serves as a paracrine mediator
of glucocorticoid action between folliculo-stellate cells and corticotrophs |
|
|
Tierney T, Christian HC, Morris JF & Buckingham JC |
| |
|
|
| OC18 |
10.45 |
The
role of phosphorylation in mediating the annexin 1-dependent actions
of glucocorticoids in the anterior pituitary gland |
|
|
John C, Morris JF, Flower R & Buckingham JC |
| |
|
|
| OC19 |
11.00 |
Adrenal
agouti related protein (AGRP) expression is regulated by glucocorticoids
and AGRP via the MC3-R or MC4-R may have an inhibitory paracrine role
on corticosterone secretion |
|
|
Dhillo WS, Small CJ, Gardiner JV, Bewick GA, Whitworth
EJ, Jethwa PH, Seal LJ, Ghatei MA, Hinson JP & Bloom SR |
| |
|
|
| OC20 |
11.15 |
The
regulation of steroidogenic acute regulatory (StAR) protein gene in human
epidermal keratinocytes |
|
|
Patel MC, Fowkes RC & Burrin JM |
| |
|
|
| OC21 |
11.30 |
Expression
of 11B-hydroxysteroid dehydrogenase (11BHSD) proteins in luteinizing
human granulosa-lutein cells: Evidence for production of a paracrine/autocrine
ovarian inhibitor of 11BHSD1 activity |
|
|
Thurston LM, Chin E, Jonas KC, Abayasekara DRE & Michael
AE |
| |
|
|
| OC22 |
11.45 |
Agonist
activated adrenocorticotropin receptor internalises via a clathrin-mediated
G-protein coupled receptor kinase dependent mechanism |
|
|
Baig AH, Hunyady L & Clark AJL |
| |
|
|
| OC23 |
12.00 |
Enhanced
5alpha-reductase activity in women with polycystic ovary syndrome (PCOS): in
vivo evidence for regulation by insulin |
|
|
Tsilchorozidou T, Honour J, Nelson C & Conway GS |
| |
|
|
| OC24 |
12.15 |
A
longer term trial of DHEA replacement in Addison's Disease |
|
|
Gurnell EM, Hunt PJ, Curran SE, Conway CL, Huppert FA,
Herbert J & Chatterjee VKK |
| |
|
|
| 12.30 - 13.00 |
Osler Room |
|
|
LUNCH |
| |
|
|
| 13.00 - 14.30 |
Library |
|
|
Attended Posters |
| |
|
|
| 13.30 - 14.30 |
Wolfson Theatre |
|
|
Clinical Endocrine Debate: "This house
believes that optimal testosterone replacement therapy is unobtainable" |
|
|
Chair: Bevan J (Aberdeen) |
|
|
Proposer: Wu F (Manchester) |
|
|
Opposer: Bouloux P (London) |
| |
|
|
| 14.30 - 16.30 |
Wolfson Theatre |
|
|
Symposium 4: Maintenance of pregnancy |
|
|
Chair: Critchley H (Edinburgh) & White J (London) |
| |
|
|
| S17 |
14.30 |
Paracrine
control of uterine differentiation and implantation |
|
|
Jabbour HN (Edinburgh), Critchley HOD & Gubbay O |
| |
|
|
| S18 |
15.00 |
Cell
biology of embryo-implantation: unraveling the role of leukaemia inhibitory
factor |
|
|
Fouladi Nashta AA, Schofield G, Andreu CV, Nijjar N, Smith
AG, Heath JK & Kimber SJ (Manchester) |
| |
|
|
| S19 |
15.30 |
Immunology
of implantation and pregnancy |
|
|
Sargent IL (Oxford), Sacks GP & Redman CWG |
| |
|
|
| S20 |
16.00 |
Endocrinology
of labour and pre-term complications |
|
|
Bennett P (London) |
| |
|
|
| 14.30 - 16.30 |
Council Chamber |
|
|
Oral Communication 4: Neuroendocrinology and diabetes |
|
|
Chair: Gillies GE (London) & Christie M (London) |
| |
|
|
| OC25* |
14.30 |
Gonadotrophin
releasing hormone regulates expression and cellular distribution of Fanconi
Anaemia A |
|
|
Larder R, Chang L & Brown P |
| |
|
|
| OC26 |
14.45 |
Pre-
and postnatal dexamethasone treatment differentially alter the expression
of annexin 1 and NOS-2 in adult rat thymus |
|
|
Lamfon HA, Theogaraj E, John CD, Smith SF, Gillies GE & Buckingham
JC |
| |
|
|
| OC27 |
15.00 |
Co-localisation
of ATP-binding cassette transporter 1 (ABCA1) and annexin I in folliculo-stellate
cells |
|
|
Christian HC, Kamitani T, Nishino S, Buckingham JC & Morris
JF |
| |
|
|
| OC28 |
15.15 |
Hypothalamic-pituitary
(h-p) irradiation resets the osmostat with upward shift in plasma osmolality |
|
|
Darzy K, Mukherjee A, Wieringa G & Shalet SM |
| |
|
|
| OC29* |
15.30 |
Novel
melanocortin 2 receptor (ACTH receptor) splice variant found in 3T3-L1
adipocytes - a system lacking SF-1 |
|
|
Noon LA, Clark AJL & King PJ |
| |
|
|
| OC30 |
15.45 |
Investigation
of impaired insulin action in cultured skeletal muscle from type 2 diabetes
mellitus |
|
|
McIntyre EA, Halse R, Yeaman SJ & Walker M |
| |
|
|
| OC31 |
16.00 |
Effect
of combined hormone replacement therapy on glucose metabolism in postmenopausal
women with type 2 diabetes: A randomised controlled trial |
|
|
Kernohan AFB, Lumsden MA, Cleland S, Petrie JR & Connell
JMC |
| |
|
|
| OC32 |
16.15 |
The
effects of thiazolidinedione and biguanide combination therapy on serum
lipid concentrations and glycemic control in patients with type 2 diabetes |
|
|
Buse JB, Peters Harmel AL, Kendall DM, Boyle PJ & Marchetti
A |